209 related articles for article (PubMed ID: 26932576)
21. LXRα regulates macrophage arginase 1 through PU.1 and interferon regulatory factor 8.
Pourcet B; Feig JE; Vengrenyuk Y; Hobbs AJ; Kepka-Lenhart D; Garabedian MJ; Morris SM; Fisher EA; Pineda-Torra I
Circ Res; 2011 Aug; 109(5):492-501. PubMed ID: 21757649
[TBL] [Abstract][Full Text] [Related]
22. Spi-C has opposing effects to PU.1 on gene expression in progenitor B cells.
Schweitzer BL; Huang KJ; Kamath MB; Emelyanov AV; Birshtein BK; DeKoter RP
J Immunol; 2006 Aug; 177(4):2195-207. PubMed ID: 16887979
[TBL] [Abstract][Full Text] [Related]
23. PU.1 and ICSBP control constitutive and IFN-gamma-regulated Tlr9 gene expression in mouse macrophages.
Schroder K; Lichtinger M; Irvine KM; Brion K; Trieu A; Ross IL; Ravasi T; Stacey KJ; Rehli M; Hume DA; Sweet MJ
J Leukoc Biol; 2007 Jun; 81(6):1577-90. PubMed ID: 17360957
[TBL] [Abstract][Full Text] [Related]
24. Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance.
Cattoretti G; Shaknovich R; Smith PM; Jäck HM; Murty VV; Alobeid B
J Immunol; 2006 Nov; 177(10):6930-9. PubMed ID: 17082608
[TBL] [Abstract][Full Text] [Related]
25. The Transcription Factors PU.1 and IRF4 Determine Dendritic Cell-Specific Expression of RALDH2.
Yashiro T; Yamaguchi M; Watanuki Y; Kasakura K; Nishiyama C
J Immunol; 2018 Dec; 201(12):3677-3682. PubMed ID: 30413670
[TBL] [Abstract][Full Text] [Related]
26. Zinc finger-IRF composite elements bound by Ikaros/IRF4 complexes function as gene repression in plasma cell.
Ochiai K; Kondo H; Okamura Y; Shima H; Kurokochi Y; Kimura K; Funayama R; Nagashima T; Nakayama K; Yui K; Kinoshita K; Igarashi K
Blood Adv; 2018 Apr; 2(8):883-894. PubMed ID: 29669755
[TBL] [Abstract][Full Text] [Related]
27. PU.1 exhibits partial functional redundancy with Spi-B, but not with Ets-1 or Elf-1.
Garrett-Sinha LA; Dahl R; Rao S; Barton KP; Simon MC
Blood; 2001 May; 97(9):2908-12. PubMed ID: 11313289
[TBL] [Abstract][Full Text] [Related]
28. PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors.
DeKoter RP; Lee HJ; Singh H
Immunity; 2002 Feb; 16(2):297-309. PubMed ID: 11869689
[TBL] [Abstract][Full Text] [Related]
29. The molecular choreography of IRF4 and IRF8 with immune system partners.
Singh H; Glasmacher E; Chang AB; Vander Lugt B
Cold Spring Harb Symp Quant Biol; 2013; 78():101-4. PubMed ID: 24752218
[TBL] [Abstract][Full Text] [Related]
30. IRF8 and IRF3 cooperatively regulate rapid interferon-β induction in human blood monocytes.
Li P; Wong JJ; Sum C; Sin WX; Ng KQ; Koh MB; Chin KC
Blood; 2011 Mar; 117(10):2847-54. PubMed ID: 21228327
[TBL] [Abstract][Full Text] [Related]
31. Accelerated plasma-cell differentiation in Bach2-deficient mouse B cells is caused by altered IRF4 functions.
Ochiai K; Shima H; Tamahara T; Sugie N; Funayama R; Nakayama K; Kurosaki T; Igarashi K
EMBO J; 2024 May; 43(10):1947-1964. PubMed ID: 38605225
[TBL] [Abstract][Full Text] [Related]
32. Multiple Ets factors and interferon regulatory factor-4 modulate CD68 expression in a cell type-specific manner.
O'Reilly D; Quinn CM; El-Shanawany T; Gordon S; Greaves DR
J Biol Chem; 2003 Jun; 278(24):21909-19. PubMed ID: 12676954
[TBL] [Abstract][Full Text] [Related]
33. Cooperation of PU.1 With IRF8 and NFATc1 Defines Chromatin Landscapes During RANKL-Induced Osteoclastogenesis.
Izawa N; Kurotaki D; Nomura S; Fujita T; Omata Y; Yasui T; Hirose J; Matsumoto T; Saito T; Kadono Y; Okada H; Miyamoto T; Tamura T; Aburatani H; Tanaka S
J Bone Miner Res; 2019 Jun; 34(6):1143-1154. PubMed ID: 30721543
[TBL] [Abstract][Full Text] [Related]
34. Expression of the interferon regulatory factor 8/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker.
Martinez A; Pittaluga S; Rudelius M; Davies-Hill T; Sebasigari D; Fountaine TJ; Hewitt S; Jaffe ES; Raffeld M
Am J Surg Pathol; 2008 Aug; 32(8):1190-200. PubMed ID: 18580679
[TBL] [Abstract][Full Text] [Related]
35. Analysis of gene expression and Ig transcription in PU.1/Spi-B-deficient progenitor B cell lines.
Schweitzer BL; DeKoter RP
J Immunol; 2004 Jan; 172(1):144-54. PubMed ID: 14688320
[TBL] [Abstract][Full Text] [Related]
36. Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers.
Brass AL; Zhu AQ; Singh H
EMBO J; 1999 Feb; 18(4):977-91. PubMed ID: 10022840
[TBL] [Abstract][Full Text] [Related]
37. The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.
Banerjee S; Lu J; Cai Q; Saha A; Jha HC; Dzeng RK; Robertson ES
PLoS Pathog; 2013; 9(5):e1003314. PubMed ID: 23658517
[TBL] [Abstract][Full Text] [Related]
38. PU.1 Regulates Ig Light Chain Transcription and Rearrangement in Pre-B Cells during B Cell Development.
Batista CR; Li SK; Xu LS; Solomon LA; DeKoter RP
J Immunol; 2017 Feb; 198(4):1565-1574. PubMed ID: 28062693
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide comparison of PU.1 and Spi-B binding sites in a mouse B lymphoma cell line.
Solomon LA; Li SK; Piskorz J; Xu LS; DeKoter RP
BMC Genomics; 2015 Feb; 16(1):76. PubMed ID: 25765478
[TBL] [Abstract][Full Text] [Related]
40. Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1.
Brass AL; Kehrli E; Eisenbeis CF; Storb U; Singh H
Genes Dev; 1996 Sep; 10(18):2335-47. PubMed ID: 8824592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
